Skip to content

Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

Variations in genital shedding of HIV during menstrual cycle large enough to impact on risk of sexual transmission

Low nadir CD4 cell count associated with increased cataract risk in South Africans taking HIV therapy

Earlier treatment in South African cohort did not increase loss to follow-up

Classic characteristics of old age associated with poor physical function in middle-aged people living with HIV

Many people with HIV not disclosing at GUM clinics: estimates of undiagnosed infections may be too high

Triple trouble: infection with hepatitis B increases risk of death for people with HIV and hepatitis C co-infection

Combining tenofovir with FTC or 3TC boosts chances of HBV suppression for people co-infected with HIV